13
Views
11
CrossRef citations to date
0
Altmetric
Articles

Prevention of Delayed Emesis by a Single Intravenous Bolus Dose of 5-HT3-Receptor- Antagonist in Moderately Emetogenic Chemotherapy

Pages 237-242 | Published online: 18 Jul 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Giovana Paula Rezende Simino, Lays Pires Marra, Eli Iola Gurgel de Andrade, Francisco de Assis Acúrcio, Ilka Afonso Reis, Vânia Eloisa De Araújo & Mariângela Leal Cherchiglia. (2016) Efficacy, safety and effectiveness of ondansetron compared to other serotonin-3 receptor antagonists (5-HT3RAs) used to control chemotherapy-induced nausea and vomiting: systematic review and meta-analysis. Expert Review of Clinical Pharmacology 9:9, pages 1183-1194.
Read now
Thomas Müller. (2009) Role of intraspinal steroid application in patients with multiple sclerosis. Expert Review of Neurotherapeutics 9:9, pages 1279-1287.
Read now
Suzanne M Walton. (2000) Advances in use of the 5-HT3 receptor antagonists. Expert Opinion on Pharmacotherapy 1:2, pages 207-223.
Read now

Articles from other publishers (8)

K. Jordan, A. Hinke, A. Grothey, W. Voigt, D. Arnold, H.-H. Wolf & H.-J. Schmoll. (2007) A meta-analysis comparing the efficacy of four 5-HT3-receptor antagonists for acute chemotherapy-induced emesis. Supportive Care in Cancer 15:9, pages 1023-1033.
Crossref
Kerstin Hellwig, Sebastian Schimrigk, Carsten Lukas, Volker Hoffmann, Nils Brune, Horst Przuntek & Thomas Muller. (2006) Efficacy of Mitoxantrone and Intrathecal Triamcinolone Acetonide Treatment in Chronic Progressive Multiple Sclerosis Patients. Clinical Neuropharmacology 29:5, pages 286-291.
Crossref
Paul L.R. Andrews & Charles C. Horn. (2006) Signals for nausea and emesis: Implications for models of upper gastrointestinal diseases. Autonomic Neuroscience 125:1-2, pages 100-115.
Crossref
Ronald de Wit, Matti Aapro & Peter R Blower. (2005) Is there a pharmacological basis for differences in 5-HT3-receptor antagonist efficacy in refractory patients?. Cancer Chemotherapy and Pharmacology 56:3, pages 231-238.
Crossref
Matti Aapro. (2005) 5-HT<sub>3</sub>-Receptor Antagonists in the Management of Nausea and Vomiting in Cancer and Cancer Treatment. Oncology 69:2, pages 97-109.
Crossref
Karin Jordan, Axel Hinke, Axel Grothey & Hans Joachim Schmoll. (2004) Granisetron versus tropisetron for prophylaxis of acute chemotherapy-induced emesis: a pooled analysis. Supportive Care in Cancer 13:1, pages 26-31.
Crossref
J. Watters, M. Riley, I. Pedley, A. Whitehead, M. Overend, I. Goss & V. Allgar. (2001) The Development of a Protocol for the Use of 5–HT3 Antagonists in Chemotherapy-Induced Nausea and Vomiting. Clinical Oncology 13:6, pages 422-426.
Crossref
Auro del Giglio, Heloisa P. Soares, Carla Caparroz & Paulo C. Castro. (2000) Granisetron is equivalent to ondansetron for prophylaxis of chemotherapy-induced nausea and vomiting. Cancer 89:11, pages 2301-2308.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.